Y-Mabs Therapeutics Inc (NQ: YMAB )
11.54
-0.06
(-0.52%)
Streaming Delayed Price
Updated: 12:43 PM EDT, May 20, 2024
Add to My Watchlist
Headline News about Y-Mabs Therapeutics IncVia Benzinga
Y-mAbs Asked To Submit Additional Granularity Of Data For Omburtamab In Nerve Tissue Cancer
April 20, 2021
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|